LDHA and adrenal cortex carcinoma: The results, presented in the forest plot (Figure 3A), demonstrated that LDHA mRNA levels could serve as a prognostic molecular marker in patients with adrenocortical carcinoma (ACC), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), Brain lower grade glioma (LGG), LIHC, LUAD, and pancreatic adenocarcinoma (PAAD).